These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7233887)

  • 41. Production of antibody to hepatitis B surface antigen (anti-HBs) by murine hepatitis B virus carriers: neonatal tolerance versus antigen presentation by dendritic cells.
    Kurose K; Akbar SM; Yamamoto K; Onji M
    Immunology; 1997 Dec; 92(4):494-500. PubMed ID: 9497491
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The frequency of detecting antibodies to the delta antigen in virtually healthy HBsAg and anti-HBs carriers in Ulan-Bator].
    Nimadava P; Anan'ev VA; Oiuunbileg Zh; Chernovetskiĭ MA
    Vopr Virusol; 1988; 33(2):246-7. PubMed ID: 3414072
    [No Abstract]   [Full Text] [Related]  

  • 43. [Immunoglobulins and antibodies in the blood serum of blood donors - HBsAg carriers].
    Chrostowska H; Zółtowska A
    Pol Tyg Lek; 1980 Nov; 35(45):1721-3. PubMed ID: 7220371
    [No Abstract]   [Full Text] [Related]  

  • 44. Occult hepatitis B virus infection among Iranian blood donors: a preliminary study.
    Alizadeh Z; Milani S; Sharifi Z
    Arch Iran Med; 2014 Feb; 17(2):106-7. PubMed ID: 24527970
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterisation and follow-up study of occult hepatitis B virus infection in anti-HBc-positive qualified blood donors in southern China.
    Ye X; Li T; Xu X; Du P; Zeng J; Zhu W; Yang B; Li C; Allain JP
    Blood Transfus; 2017 Jan; 15(1):6-12. PubMed ID: 27416568
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunological aspects of cryoprecipitates from the sera of chronic HBsAg carriers.
    Tiku ML; Beutner KR; Ogra PL
    Clin Exp Immunol; 1979 Apr; 36(1):54-62. PubMed ID: 466862
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Research on a new hepatitis B antigen-antibody system: e-anti-e.
    Ortona L; Pizzigallo E; Federico G; Camilli G; Scian J
    Boll Ist Sieroter Milan; 1977 Nov; 56(5):467-75. PubMed ID: 597398
    [No Abstract]   [Full Text] [Related]  

  • 48. [Clinical dentistry and B-type hepatitis--studies of HBs antigen and antibody carriers at Tohoku University Dental Hospital].
    Shikai Tenbo; 1979 Sep; 54(3):443-7. PubMed ID: 291532
    [No Abstract]   [Full Text] [Related]  

  • 49. Absence or delayed appearance of hepatitis B core antibody in chronic hepatitis B surface antigen carrier children.
    Ni YH; Hsu HY; Chang MH; Chen DS; Lee CY
    J Hepatol; 1993 Feb; 17(2):150-4. PubMed ID: 8445229
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Markers of hepatitis B virus infection in infants born of mothers who are HBs-antigen carriers with anti-HBe present and the problems of passive immunoprophylaxis].
    Kuzin SN; Shakhgil'dian IV; Farber NA; Mikhaĭlov MI; Vorozhbieva TE
    Vopr Virusol; 1987; 32(1):59-63. PubMed ID: 3577108
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anti-HBs reactivity in hepatitis B surface antigen positive serum samples--with special emphasis on heterotypic antibody.
    Chen DS; Lai MY; Sung JL
    Taiwan Yi Xue Hui Za Zhi; 1982 Nov; 81(11):1357-64. PubMed ID: 6298339
    [No Abstract]   [Full Text] [Related]  

  • 52. Viral hepatitis, type B, DNA polymerase activity and antibody to hepatitis B core antigen.
    Krugman S; Hoofnagle JH; Gerety RJ; Kaplan PM; Gerin JL
    N Engl J Med; 1974 Jun; 290(24):1331-5. PubMed ID: 4827643
    [No Abstract]   [Full Text] [Related]  

  • 53. [Latent HBV infection in single blood donors].
    Fedorchenko SV; Zanevskaia LI; Burma NM; Borisevich OS; Balitskaia TE; Iurchenko LF; Martynovich TL
    Vopr Virusol; 2008; 53(3):23-5. PubMed ID: 18590131
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A large-scale survey on the prevalence of HBeAG and anti-HBe among asymptomatic carriers of HBV. Correlation with sex, age, HBsAG titre and s-GPT value.
    Sasaki T; Hattori T; Mayumi M
    Vox Sang; 1979; 37(4):216-21. PubMed ID: 494592
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hepatitis B virus and primary hepatocellular carcinoma: family studies in Korea.
    Hann HW; Kim CY; London WT; Whitford P; Blumberg BS
    Int J Cancer; 1982 Jul; 30(1):47-51. PubMed ID: 6288579
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatitis B surface antigen and antibody. A prospective study in asymptomatic drug abusers.
    Stimmel B; Vernace S; Schaffner F
    JAMA; 1975 Dec; 234(11):1135-8. PubMed ID: 810605
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The prevalence of hepatitis-B antigen (HB S Ag) and its antibody (Anti-HB S) among London hemophiliacs and blood donors from London and two tropical areas.
    Islam MN; Banatvala JE
    Transfusion; 1976; 16(3):237-41. PubMed ID: 936273
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Anti-core antibody in HBsAg negative subjects].
    Ferroni P; Quartodipalo ME; Zanetti AR
    Boll Ist Sieroter Milan; 1978 Nov; 57(5):676-9. PubMed ID: 556542
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Experience in detecting donors as sources of serum hepatitis infection].
    Starshov PD; Ianvareva NM; Saenko VM; Prudnikov LM; Kotov BP
    Probl Gematol Pereliv Krovi; 1974 Sep; 19(9):53-5. PubMed ID: 4617878
    [No Abstract]   [Full Text] [Related]  

  • 60. Antibody against the hepatitis type B core antigen. A new tool for epidemiologic studies.
    Szmuness W; Hoofnagle JH; Stevens CE; Prince AM
    Am J Epidemiol; 1976 Sep; 104(3):256-62. PubMed ID: 989260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.